Why Will Proton Therapy Rule the Particle Therapy Market?

The major drivers in the global particle therapy market are the rising count of particle therapy centers and the swift integration of this therapy for cancer treatment. In 2021, the sales revenue of the products used for such treatments stood at $797.1 million, and it is predicted to touch $1,634.4 million by 2030. The market will advance at an 8.3% CAGR from 2021 to 2030. Additionally, the highly competitive market players continuously participate in mergers and acquisitions for not only the swift deployment of technologically advanced devices but also for the development of new products in the market. Therefore, all of this will amplify the market growth.

Market Overview@ https://www.psmarketresearch.com/market-analysis/particle-therapy-market

Furthermore, there are 2 million breast cancer deaths globally every year, as per the WHO. The rising incidence of breast cancer will spur the particle therapy market growth. Moreover, the number of lung cancer patients is exceeded by the global count of breast cancer patients, being the most common cancer. Furthermore, proton therapy is extensively used in all the phases of breast cancer treatment. This integration is on account of its inherent benefits, such as high linear energy distribution (LET) of charged particles and efficient depth-dose distribution, propelling growth in the market.

Additionally, there is a surging inclination of research centers & hospitals, and academics toward proton therapy equipment because of its economic aspects over the heavy ion therapy. Apart from the reduced installation costs in this therapy, they do not affect the normal healthy body cells. This is backed by this therapy's ability to attack the ions in the first place without disturbing these cells. Moreover, protons are lighter than ions, consequently resulting in reduced costs for the setup of these centers. Furthermore, this procedure not only leaves minimal side effects but also saves time.

To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/particle-therapy-market/report-sample

Accounting for at least 80% of the global particle therapy market share, products, including synchrocyclotrons, synchrotrons, and cyclotrons, witness the highest sales. This can be ascribed to their advantages including the economic aspects and the rising deployment of cyclotrons in numerous healthcare centers. Moreover, the increasing accessibility of innovative diagnostic devices, coupled with the surging preference for nuclear scans for diagnosis. Apart from the low cost of cyclotrons, they also are minute over the synchrotrons.

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.